Skip to content

Feeding Tube in Cancer Patients

A Randomized Comparison of Enteral Feeding for Head and Neck (HNC) Cancer Patients

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02675673
Enrollment
0
Registered
2016-02-05
Start date
2011-09-30
Completion date
2013-09-30
Last updated
2016-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteral Feeding for Head and Neck Cancer Patients

Keywords

Enteral Feeding, G-Tube, GJ Tube

Brief summary

The purpose of this study is to compare the quality of life (QOL) in head and neck patients who are given the GJ tube (which is placed in the bowel) versus those who are given the G-Tube (which is placed in the stomach) for prophylactic feeding. The standard of care for patients at Princess Margaret Hospital (PMH) is using GJ tubes. Patients who agree to be in the study will be randomized to either the GJ-Tube or the G-Tube arm. Patients randomized to the G-tube will receive prophylactic intravenous and oral antibiotics prior to insertion of the G-tube. Antibiotics will be given for a total of 1 week. A few hours following tube insertion (on return to PMH ward), patients will complete a single item, visual analogue pain scale (VAS). Patients will remain in hospital for a minimum of 24 hours and until the patient and/or family is able to care for the Enteric Feeding(EF) device at home. Patients randomized to the GJ-Tube may receive i.v medication during the procedure. All Patients will be asked to fill out several questionnaires at different time- points of the study. All Patients will have regular assessments to evaluate their overall quality of Life, toxicity, and how they respond to treatment during the study. Patients will also be assessed after they completed study treatment.

Detailed description

Prophylactic enteral feeding tubes are used routinely for nutritional support during intensive radiotherapy or chemoradiotherapy for locally advanced head and neck cancer. Typically, tubes remain in place for up to 3-4 months. Whether small-bore jejunal (GJ) or larger bore gastric (G) tubes are used varies geographically, based on tradition, physician preference and availability of services. Feeding tube placement is arranged either prior to the start of RT, or more commonly within the first 2 weeks of RT, prior to the onset of severe mucositis. Patients are admitted to hospital for 1-3 days to monitor side effects of the procedure, and to allow our dietetic and nursing staff to provide intensive teaching on the use and care of the tube. Feeding tubes are kept in place through the treatment course and removed once patients are able to meet their calorie needs and maintain body weight through oral feeding. On average, feeding tubes are removed approximately 2-3 months after completion of RT; however, approximately 20% of patients may still require enteral feeding at 1 year post-treatment. This study will compare the QOL in patients who use the G tube versus the GJ tube.

Interventions

PROCEDUREGJ-Tube

Insertion of a GJ tube either prior to the start of radiotherapy or within the first 2 weeks after the first dosage.

PROCEDUREG-Tube

Insertion of a G-tube either prior to the start of radiotherapy or within the first 2 weeks after the first dosage.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* local regional carcinoma of the oral cavity, pharynx, paranasal sinuses, larynx, cervical esophagus * patients who will receive potentially curative radiotherapy or chemotherapy * patients who are recommended for prophylactic enteral feeding

Exclusion criteria

* patients who are unable to give consent * patients who have other concurrent active cancer diagnosis * patients with established pharyngeal obstruction and/or presence of an EF device

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life questionnaire: Enteric Feeding (QOL-EF)1 yearA 20-item specific questionnaire scored using individual items from 1=not at all to 5=very much

Secondary

MeasureTime frameDescription
Quality of Life questionnaire: M.D.Anderson Swallowing Inventory (MDADI)1 yearA self-reported utility consisting of 20 discrete 5-level items rated from strongly agree to strongly disagree
Patient weight loss associated with the use of feeding tubes2 yearsweight will be measured at protocol-determined time points
Evaluation of post-procedure pain associated with the use of feeding tubes1 yearVisual analog scale
Quality of Life questionnaire: Functional Assessment of Cancer Therapy (FACT-HN)1 year•Quality of life as measured by Functional Assessment of Cancer Therapy-Head & Neck (FACT-HN) ranking 24 individual items from 0= not at all to 4 = very much
Symptoms associated with the use of feeding tubes (as per CTCAE v4 criteria)1 yearClinical toxicities will be grade according to Common Terminology Criteria for Adverse Events version 4.03 (CTCAE v4), a well known toxicity grading scale from 0 (asymptomatic) to 5 (death)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026